The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Tonmya
Cyclobenzaprine Hydrochloride · CYCLOBENZAPRINE HYDROCHLORIDE 2.8 mg/1 · Tablet, Orally Disintegrating · Sublingual · Tonix Medicines, Inc.
NDC 70792-0102-14 · 14 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for cyclobenzaprine hydrochloride (oral solid) in the next 90 days
OAI inspection at a producing facility (24 months) · sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Where it's made
- Almac Pharma Services LimitedUnited Kingdommanufacture
- Patheon Inc.Canadalabel · manufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- NDA219428
- TE code
- —
- Approval date
- Aug 15, 2025
- Patents / exclusivity
- 4 patents, 1 exclusivities
| Type | Number / code | Expires |
|---|---|---|
| exclusivity | NP | Aug 15, 2028 |
| patent | 10117936 | Mar 14, 2034 |
| patent | 10864175 | Mar 14, 2034 |
| patent | 9636408 | Mar 14, 2034 |
| patent | 9956188 | Mar 14, 2034 |
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Cyclobenzaprine Hydrochloride (Tablet, Orally Disintegrating)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Tonix Medicines, Inc. | CYCLOBENZAPRINE HYDROCHLORIDE 2.8 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Tonmya — NDC 70792-0102-14," retrieved September 3, 2026, https://drugdashboards.com/drug/70792010214.
Free to cite with attribution — see how the data is put together.